Iadecola C, Smith EE, Anrather J, Gu C, Mishra A, Misra S, et al. The neurovasculome: key roles in brain health and cognitive impairment: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2023;54:e251.

Article  PubMed  PubMed Central  Google Scholar 

Fisher RA, Miners JS, Love S. Pathological changes within the cerebral vasculature in Alzheimer’s disease: new perspectives. Brain Pathol. 2022;32(6):e13061.

Article  PubMed  PubMed Central  Google Scholar 

Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, et al. Clearance systems in the brain—implications for Alzheimer disease. Nat Rev Neurol. 2015;11(8):457–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14(4):535–62.

Article  PubMed  PubMed Central  Google Scholar 

Siegel GJ, Agranoff BW, Albers RW, et al., editors. Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 6th edition. Philadelphia: Lippincott-Raven; 1999.

Gottesman RF, Albert MS, Alonso A, Coker LH, Coresh J, Davis SM, et al. Associations between midlife vascular risk factors and 25-year incident dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort. JAMA Neurol. 2017;74(10):1246–54.

Article  PubMed  PubMed Central  Google Scholar 

Mosconi L, Walters M, Sterling J, Quinn C, McHugh P, Andrews RE, et al. Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer’s disease: a cross-sectional study of middle-aged adults from the broader New York City area. BMJ Open. 2018;8(3): e019362.

Article  PubMed  PubMed Central  Google Scholar 

Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer’s disease: an analysis of population-based data. Lancet Neurol. 2014;13(8):788–94.

Article  PubMed  Google Scholar 

Vu TT, Zhao L, Liu L, Schiman C, Lloyd-Jones DM, Daviglus ML, et al. Favorable cardiovascular health at young and middle ages and dementia in older age-The CHA study. J Am Heart Assoc. 2019;8(1): e009730.

Article  CAS  PubMed  Google Scholar 

Tan ECK, Qiu C, Liang Y, Wang R, Bell JS, Fastbom J, et al. Antihypertensive medication regimen intensity and incident dementia in an older population. J Am Med Dir Assoc. 2018;19(7):577–83.

Article  PubMed  Google Scholar 

Solomon A, Kivipelto M, Soininen H. Prevention of Alzheimer’s disease: moving backward through the lifespan. J Alzheimer’s Dis : JAD. 2013;33(Suppl 1):S465–9.

PubMed  Google Scholar 

Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, et al. Vascular dysfunction-The disregarded partner of Alzheimer’s disease. Alzheimer’s Dementia. 2019;15(1):158–67.

Article  PubMed  Google Scholar 

Hassler O. Vascular changes in senile brains. A Micro-Angiograph Study Acta Neuropathol. 1965;5(1):40–53.

Article  CAS  PubMed  Google Scholar 

Bell MA, Ball MJ. Morphometric comparison of hippocampal microvasculature in ageing and demented people: diameters and densities. Acta Neuropathol. 1981;53(4):299–318.

Article  CAS  PubMed  Google Scholar 

Fischer VW, Siddiqi A, Yusufaly Y. Altered angioarchitecture in selected areas of brains with Alzheimer’s disease. Acta Neuropathol. 1990;79(6):672–9.

Article  CAS  PubMed  Google Scholar 

Kalaria RN, Hedera P. Differential degeneration of the cerebral microvasculature in Alzheimer’s disease. NeuroReport. 1995;6(3):477–80.

Article  CAS  PubMed  Google Scholar 

Zipser BD, Johanson CE, Gonzalez L, Berzin TM, Tavares R, Hulette CM, et al. Microvascular injury and blood-brain barrier leakage in Alzheimer’s disease. Neurobiol Aging. 2007;28(7):977–86.

Article  CAS  PubMed  Google Scholar 

Challa VR, Thore CR, Moody DM, Anstrom JA, Brown WR. Increase of white matter string vessels in Alzheimer’s disease. J Alzheimer’s Dis: JAD. 2004;6(4):379–83.

Article  PubMed  Google Scholar 

Kuhn J, Sharman T. Cerebral Amyloid Angiopathy. [Updated 2023 Jun 5]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. https://www.ncbi.nlm.nih.gov/books/NBK556105/.

Toledo JB, Arnold SE, Raible K, Brettschneider J, Xie SX, Grossman M, et al. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s coordinating centre. Brain : A J Neurol. 2013;136(Pt 9):2697–706.

Article  Google Scholar 

Arvanitakis Z, Capuano AW, Leurgans SE, Bennett DA, Schneider JA. Relation of cerebral vessel disease to Alzheimer’s disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol. 2016;15(9):934–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Biffi A, Greenberg SM. Cerebral amyloid angiopathy: a systematic review. J Clin Neurol (Seoul, Korea). 2011;7(1):1–9.

Article  Google Scholar 

Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, et al. Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier. J Clin Investig. 2000;106(12):1489–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lam FC, Liu R, Lu P, Shapiro AB, Renoir JM, Sharom FJ, et al. β-Amyloid efflux mediated by p-glycoprotein. J Neurochem. 2001;76(4):1121–8.

Article  CAS  PubMed  Google Scholar 

Kim J, Castellano JM, Jiang H, Basak JM, Parsadanian M, Pham V, et al. Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular Aβ clearance. Neuron. 2009;64(5):632–44.

Article  PubMed  PubMed Central  Google Scholar 

Prior R, Wihl G, Urmoneit B. Apolipoprotein E, Smooth Muscle Cells and the Pathogenesis of Cerebral Amyloid Angiopathy: the Potential Role of Impaired Cerebrovascular Abeta Clearance. Annals of the New York Academy of Sciences. 2000;903(1 Vascular fact):180–6.

Hawkes CA, Jayakody N, Johnston DA, Bechmann I, Carare RO. Failure of perivascular drainage of β-amyloid in cerebral amyloid angiopathy. Brain Pathol. 2014;24(4):396–403.

Article  CAS  PubMed  PubMed Central  Google Scholar 

2020 Alzheimer's disease facts and figures. Alzheimers Dement. 2020;16(3):391–460. https://doi.org/10.1002/alz.12068.

van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer’s disease. N Engl J Med. 2022;388(1):9–21.

Article  PubMed  Google Scholar 

Mintun MA, Lo AC, Duggan Evans C, Wessels AM, Ardayfio PA, Andersen SW, et al. Donanemab in early Alzheimer’s disease. N Engl J Med. 2021;384(18):1691–704.

Article  CAS  PubMed  Google Scholar 

Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, et al. Donanemab in early symptomatic Alzheimer disease: The TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330(6):512–27.

Article  CAS  PubMed  Google Scholar 

Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S, et al. Two randomized phase 3 studies of Aducanumab in early Alzheimer’s disease. J Prev Alzheimer’s Dis. 2022;9:197.

CAS  Google Scholar 

Ostrowitzki S, Deptula D, Thurfjell L, Barkhof F, Bohrmann B, Brooks DJ, et al. Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. Arch Neurol. 2012;69(2):198–207.

Article  PubMed  Google Scholar 

Boche D, Zotova E, Weller RO, Love S, Neal JW, Pickering RM, et al. Consequence of Abeta immunization on the vasculature of human Alzheimer’s disease brain. Brain : A J Neurol. 2008;131(Pt 12):3299–310.

Article  CAS  Google Scholar 

Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol. 2004;55(2):250–6.

Article  PubMed  Google Scholar 

Scolding NJ, Joseph F, Kirby PA, Mazanti I, Gray F, Mikol J, et al. Aβ-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain. 2005;128(3):500–15.

Article  PubMed  Google Scholar 

Antolini L, DiFrancesco JC, Zedde M, Basso G, Arighi A, Shima A, et al. Spontaneous ARIA-like events in cerebral amyloid angiopathy-related inflammation. A Multicenter Prospect Longitudinal Cohort Study. 2021;97(18):e1809–22.

CAS  Google Scholar 

Sperling RA, Jack CR Jr, Black SE, Frosch MP, Greenberg SM, Hyman BT, et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer’s association research roundtable workgroup. Alzheimers Dement. 2011;7(4):367–85.

Article  PubMed  PubMed Central  Google Scholar 

Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science (New York, NY). 1993;261(5123):921–3.

Article  CAS  Google Scholar 

Castellano JM, Deane R, Gottesdiener AJ, Verghese PB, Stewart FR, West T, et al. Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosis. Proc Natl Acad Sci U S A. 2012;109(38):15502–7.

Article  CAS  PubMed  PubMed Central  Google Scholar